Clinical Trials Browser

Phase 2 × Terminated × Topotecan × Clear all

NCT02569957 2025-05-04

Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Terminated

1 enrolled 5 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01904253 2024-09-05

A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy

Phase 2 Terminated

Small Cell Lung Carcinoma

NCT02963090 2023-02-15

Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer

Phase 2 Terminated

9 enrolled 11 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00014443 2023-01-09

Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Phase 2 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01803269 2020-06-26

Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer

Phase 2 Terminated

29 enrolled 14 charts

Small Cell Lung Carcinoma

NCT00315211 2018-08-20

Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer

Phase 2 Terminated

Mediastinal Neoplasms

NCT00005029 2018-04-12

Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Phase 2 Terminated

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00808899 2017-05-30

Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma

Phase 2 Terminated

4 enrolled 5 charts

Neuroblastoma

NCT02107378 2016-11-30

Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma

Phase 2 Terminated

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

NCT01003938 2016-06-30

Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer

Phase 2 Terminated

6 enrolled 7 charts

Ovarian Neoplasms

NCT00087048 2016-03-22

Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Phase 2 Terminated

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00313612 2015-11-27

Oxaliplatin and Topotecan in Advance Ovarian Cancer

Phase 2 Terminated

39 enrolled 7 charts

Carcinoma, Ovarian Epithelial

NCT00437073 2015-10-15

Brain Metastases In ErbB2-Positive Breast Cancer

Phase 2 Terminated

22 enrolled 8 charts

Brain Neoplasms, Breast Neoplasms

NCT00003156 2013-04-11

Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus

Phase 2 Terminated

Sarcoma

NCT00006032 2012-12-11

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00888810 2009-04-28

TOPO-LAPA

Phase 2 Terminated

Neoplasms, Recurrence

NCT00194935 2006-09-13

Weekly Topotecan Therapy in Patients With Ovarian Cancer

Phase 2 Terminated

Ovarian Neoplasms